US2018364136A1PendingUtilityA1

Solution and method for adhering suspension components to a substrate

Assignee: CAMPTON DANIELPriority: Dec 2, 2015Filed: Aug 27, 2018Published: Dec 20, 2018
Est. expiryDec 2, 2035(~9.4 yrs left)· nominal 20-yr term from priority
G01N 1/30G02B 21/34G01N 2001/305A61K 47/10A61K 31/60
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This disclosure is directed to a method and an attachment solution for adhering a cytological or histological sample, such as buffy coat, to a substrate, such as a microscope slide. The attachment solution includes an attachment base, an anti-coagulant, and a nonsteroidal anti-inflammatory drug. The attachment base may be an alcohol, an acid, an oxidizer, an organohalogen, a ketone, or any combination thereof. Once a sample is obtained, the sample may be re-suspended in the attachment solution or the attachment solution may be added to the sample. The sample may then be dispensed onto an analysis platform as one or more droplets and cured.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A solution, comprising:
 an alcohol; and   a nonsteroidal anti-inflammatory drug having a final concentration of 100-1000 ug/mL,   wherein the final concentration is the concentration of the nonsteroidal anti-inflammatory drug when mixed with a sample.   
     
     
         2 . The solution of  claim 1 , wherein the alcohol is methanol. 
     
     
         3 . The solution of  claim 2 , wherein the non-steroidal anti-inflammatory drug is acetylsalicylic acid. 
     
     
         4 . The solution of  claim 3 , further comprising a buffer. 
     
     
         5 . The solution of  claim 3 , further comprising a salt, wherein the solution is hypotonic relative to the sample. 
     
     
         6 . The solution of  claim 1 , wherein the alcohol has a final concentration of 60-70% by volume when mixed with the sample. 
     
     
         7 . The solution of  claim 1 , further comprising water. 
     
     
         8 . The solution of  claim 1 , further comprising a buffered solution. 
     
     
         9 . The solution of  claim 1 , further comprising an anti-coagulant. 
     
     
         10 . The solution of  claim 9 , wherein the anti-coagulant is heparin.

Join the waitlist — get patent alerts

Track US2018364136A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.